Go
View All
FIGURE NET DUODENUM and AMPULLA OF VATER-ANATOMY
FIGURE NET DUODENUM and AMPULLA OF VATER-NODAL MAP
FIGURE NET DUODENUM and AMPULLA OF VATER-T1 AMPULLA
FIGURE NET DUODENUM and AMPULLA OF VATER-T2 AMPULLA
FIGURE NET DUODENUM and AMPULLA OF VATER-T3
FIGURE NET JEJUNUM and ILEUM-ANATOMY
FIGURE NET JEJUNUM and ILEUM-N2
FIGURE NET JEJUNUM and ILEUM-SURVIVAL, PATHOLOGICAL
FIGURE NET JEJUNUM and ILEUM-T2
FIGURE NET JEJUNUM and ILEUM-T4
FIGURE NET PANCREAS-NODAL MAP
FIGURE NET PANCREAS-T1, T2
FIGURE NET PANCREAS-T4
FIGURE NET STOMACH-N1
FIGURE NET STOMACH-SURVIVAL, CLINICAL
FIGURE NET STOMACH-T2
FIGURE NET STOMACH-T4
Five-year overall survival of 2,465 MCC patients with regional lymph node metastases in the NCDB, stratified by tumor burden and primary tumor status: clinically and radiologically occult nodal metastasis (N1a) detected by SLNB or otherwise; clinically or radiologically detected and pathologically confirmed nodal metastasis (N1b) with or without the presence of a primary tumor; and in-transit disease (N2)
Five-year overall survival of 6,127 patients with local MCC only (clinically and, if known, pathologically node negative) in the NCDB, stratified by T category ( 2 cm, T1; 2 cm, T2/3; involving fascia, muscle, cartilage, or bone, T4)
For appendicular skeleton, trunk, skull, and facial bones, T1 is defined as tumor 8 cm or less in greatest dimension
For appendicular skeleton, trunk, skull, and facial bones, T3 is defined as discontinuous tumors in the primary bone site
For carcinomas T1b is tumor invading one half or more of the myometrium
For carcinomas T3a is tumor involving the serosa and/or adnexa (direct extension or metastasis)
FIGURE NET PANCREAS-N1
FIGURE NET PANCREAS-SURVIVAL, PATHOLOGICAL
FIGURE NET PANCREAS-T3
FIGURE NET STOMACH-ANATOMY
FIGURE NET STOMACH-NODAL MAP
FIGURE NET STOMACH-T1
FIGURE NET STOMACH-T3
Displaying items 31 - 60 of 67